The aim of this study is to assess the prevalence of distress, anxiety and psychosexual anguish in patients diagnosed with borderline ovarian tumor (BOT) compared to controls confronted with surgical treatment for benign ovarian tumors.
Age range
18 Years – 100 Years
Sex
FEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Anxiety and Depression - HADS
Timeframe: 2020
Depression - BIS
Timeframe: 2020
Anxiety - Perceived Stress Scale
Timeframe: 2020
Psycho-sexual health - FSFI
Timeframe: 2020
Psycho-sexual health - FSDS - Revised
Timeframe: 2020
Psycho-sexual health - EORTC OV28
Timeframe: 2020
Psycho-sexual health - EORTC SHQ C22
Timeframe: 2020